| 6941 |
Dual-hemisphere repetitive transcranial magnetic stimulation for rehabilitation of poststroke aphasia: a randomized, double-blind clinical trial. |
Department of Neurology and Psychiatry |
2014 |
| 6942 |
Dual-hemisphere repetitive transcranial magnetic stimulation for rehabilitation of poststroke aphasia: a randomized, double-blind clinical trial. |
Department of Neurology and Psychiatry |
2014 |
| 6943 |
Dual-hemisphere repetitive transcranial magnetic stimulation for rehabilitation of poststroke aphasia: a randomized, double-blind clinical trial. |
Department of Neurology and Psychiatry |
2014 |
| 6944 |
Dual-hemisphere repetitive transcranial magnetic stimulation for rehabilitation of poststroke aphasia: a randomized, double-blind clinical trial. |
Department of Neurology and Psychiatry |
2014 |
| 6945 |
Dual-hemisphere repetitive transcranial magnetic stimulation for rehabilitation of poststroke aphasia: a randomized, double-blind clinical trial. |
Department of Neurology and Psychiatry |
2014 |
| 6946 |
Duplex-guided Percutaneous Transluminal Balloon Angioplasty of Superficial Femoral Artery-Single Center Experience |
Department of Diagnostic Radiology |
2014 |
| 6947 |
Early sheath removal after percutaneous coronary intervention using Assiut Femoral Compression Device is feasible and safe. Results of a randomized controlled trial |
Department of Cardiology |
2014 |
| 6948 |
Early sheath removal after percutaneous coronary intervention using Assiut Femoral Compression Device is feasible and safe. Results of a randomized controlled trial |
Department of Cardiology |
2014 |
| 6949 |
Early sheath removal after percutaneous coronary intervention using Assiut Femoral Compression Device is feasible and safe. Results of a randomized controlled trial |
Department of Cardiology |
2014 |
| 6950 |
Effect of addition od dexamethasone to Bupivacaine in ultrasound guided supraclavicular brachial plexus blockade in patients undergoing upper limb vascular surgery. |
Department of Anesthesia and Intensive Care |
2014 |
Do you have any questions? 
